Photo of Rodney F. Pommier, M.D.

Rodney F. Pommier M.D.

  • (503) 494-5501
    • Professor of Surgery, Division of Surgical Oncology School of Medicine

Among Dr. Pommier`s clinical interests are breast surgery, colorectal surgery, hepatobiliary, pancreatic surgery, thoracic surgery and sarcoma surgery and carcinoid cancer. His research interests are breast cancer, endocrine tumors, sarcomas, melanomas and carcinoid cancer. Dr. Pommier received his medical degree from OHSU in 1983 and continued his medical education at OHSU by completing his general surgery residency. He completed two surgical oncology fellowships, one with the American Cancer Society at OHSU, the second at Memorial Sloan Kettering Cancer Center in New York.

Education

  • M.D., Oregon Health & Science University, Portland Oregon 1983
  • Residency:

    • General Surgery, Oregon Health & Science University, 1990
  • Fellowship:

    • American Cancer Society, Oregon Health & Science University
    • Memorial Sloan Kettering Cancer Center, New York, New York
  • Certifications:

    • American Board of Surgery, 1991

Publications

  • "LANREOTIDE THERAPY in CARCINOID SYNDROME : PROSPECTIVE ANALYSIS of PATIENT-REPORTED SYMPTOMS in PATIENTS RESPONSIVE to PRIOR OCTREOTIDE THERAPY and PATIENTS NAÏVE to SOMATOSTATIN ANALOGUE THERAPY in the ELECT PHASE 3 STUDY." Endocrine Practice In: , Vol. 24, No. 3, 01.03.2018, p. 243-255.
  • "Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel : Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study." Oncologist  In: , Vol. 23, No. 1, 01.01.2018, p. 16-24.
  • "Editorial : Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms." Surgery (United States) In: , 01.01.2018.
  • "Impact of prior therapies on everolimus activity : An exploratory analysis of RADIANT-4." OncoTargets and Therapy  In: , Vol. 10, 16.10.2017, p. 5013-5030.
  • "Expert commentary on neuroendocrine tumors of the colon and rectum." Diseases of the Colon and Rectum In: , Vol. 60, No. 10, 01.10.2017, p. 1021-1022.
  • "Enhancing an oncologist’s recommendation to exercise to manage fatigue levels in breast cancer patients : a randomized controlled trial." Supportive Care in Cancer  In: , 30.09.2017, p. 1-8.
  • "Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary." Neuroendocrinology  In: , 24.05.2017.
  • "Expanded criteria for debulking of liver metastasis also apply to pancreatic neuroendocrine tumors." Surgery (United States) In: , 01.01.2017.
  • "The north American neuroendocrine tumor society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors." Pancreas In: , Vol. 46, No. 6, 2017, p. 707-714.
  • "The surgical management of small bowel neuroendocrine tumors." Pancreas In: , Vol. 46, No. 6, 2017, p. 715-731.
  • "Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4) : A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial." The Lancet Oncology In: , 2017.
  • "Everolimus for the treatment of advanced pancreatic neuroendocrine tumors : Overall survival and circulating biomarkers from the randomized, Phase III RADIANT-3 study." Journal of Clinical Oncology  In: , Vol. 34, No. 32, 10.11.2016, p. 3906-3913.
  • "Cystic neutrophilic granulomatous mastitis : Association with gram-positive bacilli and corynebacterium." American Journal of Clinical Pathology In: , Vol. 145, No. 5, 01.05.2016, p. 635-645.
  • "Surgical Treatment of Small Bowel Neuroendocrine Tumors." Hematology/Oncology Clinics of North America In: , Vol. 30, No. 1, 01.02.2016, p. 49-61.
  • "Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis." Surgery (United States) In: , Vol. 159, No. 1, 01.01.2016, p. 358-365.
  • "Treatment of Neuroendocrine Liver Metastases." Surgical Oncology Clinics of North America In: , Vol. 25, No. 1, 01.01.2016, p. 217-225.
  • "Gene expression signatures of breast cancer stem and progenitor cells do not exhibit features of Warburg metabolism." Stem Cell Research and Therapy In: , Vol. 6, No. 1, 157, 28.08.2015.
  • "Impact of prior chemotherapy use on the efficacy of everolimus in patients with advanced pancreatic neuroendocrine tumors a subgroup analysis of the phase III RADIANT-3 trial." Pancreas  In: , Vol. 44, No. 2, 2015, p. 181-189.
  • "Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations." BMC Cancer In: , Vol. 14, No. 1, 733, 30.09.2014.
  • "The international normalized ratio overestimates coagulopathy in patients after major hepatectomy." American Journal of Surgery In: , Vol. 207, No. 5, 2014, p. 723-727.
  • "Expanded criteria for carcinoid liver debulking : Maintaining survival and increasing the number of eligible patients." Surgery (United States) In: , Vol. 156, No. 6, 2014, p. 1369-1376.
  • "Phase i trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates." Clinical Cancer Research In: , Vol. 19, No. 24, 15.12.2013, p. 6902-6911.
  • "Coagulopathy after a liver resection : Is it over diagnosed and over treated?" HPB In: , Vol. 15, No. 11, 11.2013, p. 865-871.
  • "Correlation of breast cancer axillary lymph node metastases with stem cell Mutations." JAMA Surgery In: , Vol. 148, No. 9, 09.2013, p. 873-878.
  • "Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients." Journal of Surgical Oncology  In: , Vol. 107, No. 8, 06.2013, p. 842-846.
  • "Laparoscopic surgical exploration is an effective strategy for locating occult primary neuroendocrine tumors." American Journal of Surgery In: , Vol. 203, No. 5, 05.2012, p. 628-631.
  • "Fresh surgical specimens yield breast stem/progenitor cells and reveal their oncogenic abnormalities." Annals of Surgical Oncology In: , Vol. 19, No. 2, 02.2012, p. 527-535.
  • "Post-transplant lymphoproliferative disorder at the site of recurrent breast abscesses." Breast Journal In: , Vol. 17, No. 5, 09.2011, p. 529-531.
  • "Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors." Journal of Hematology and Oncology  In: , Vol. 4, 29, 2011.
  • "NANETS treatment guidelines : Well-differentiated neuroendocrine tumors of the stomach and pancreas." Pancreas In: , Vol. 39, No. 6, 08.2010, p. 735-752.

Additional information

Edit profile